| Exposing fetal drug exposure. | |
| | |
MedLine Citation:
|
PMID: 21593755 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Pregnancy neither protects women from susceptibility to illness nor generally decreases drug dosage requirements of preexisting pharmacotherapy. Thus, a major concern of drug use during pregnancy is maintenance of maternal health while minimizing fetal drug exposure. Important assumptions in reproductive medicine are that fetal exposure to any medication can present risks in pregnancy-because not all risks are known, as little exposure as possible is desirable. |
| | |
Authors:
|
L Devane; L M Goetzl; S Ramamoorthy |
Related Documents
:
|
11444365 - A case of acute inflammatory demyelinating polyradiculoneuropathy in early pregnancy. 508665 - Acute proliferative glomerulonephritis with crescents and renal failure in pregnancy su... 15898935 - Characteristics of periodontal microflora in acute myocardial infarction. 19198975 - A rare pathological trinity: an appendiceal ectopic pregnancy, acute appendicitis and a... 10429765 - The emerging role of immunoregulation of fibrinogen-related procoagulant fgl2 in the su... 497145 - Fetal movements in small-for-dates babies. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical pharmacology and therapeutics Volume: 89 ISSN: 1532-6535 ISO Abbreviation: Clin. Pharmacol. Ther. Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-05-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372741 Medline TA: Clin Pharmacol Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 786-8 Citation Subset: AIM; IM |
Affiliation:
|
Department of Psychiatry, Medical University of South Carolina, Charleston, South Carolina, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The phenotype standardization project: improving pharmacogenetic studies of serious adverse drug rea...
Next Document: Drug safety sciences and the bottleneck in drug development.